EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

bla KPC-2 overexpression and bla GES-5 carriage as major imipenem/relebactam resistance mechanisms in Pseudomonas aeruginosa high-risk clones ST463 and ST235, respectively, in China

Yue Li iD, Li Fang, Mengqian Dong, Heng Cai, Xiaoting Hua iD, Yan Jiang, Yunsong Yu iD, Qing Yang

Antimicrobial Agents and Chemotherapy · 15.11.2023 · 67 (11)

DOI: 10.1128/aac.00675-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 15.11.2023. Verfasst von Yue Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine , Hangzhou, China. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), MOST | National Key Research and Development Program of China (NKPs), Merck (Merck & Co.).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pseudomonas aeruginosa high-risk clones pose severe threats to public health. Here, we characterize the imipenem/relebactam (IR) resistance mechanisms in P. aeruginosa high-risk clones sequence type 235 (ST235) and ST463 in China. Minimum inhibitory concentrations (MICs) were determined, and Illumina short-read sequencing was performed for 1,168 clinical carbapenem-resistant P. aeruginosa (CRPA) isolates. The gene copy number and expression level were analyzed by Illumina sequencing depth and reverse transcription-quantitative PCR, respectively. Resistance conferred by bla GES-5 was evaluated by cloning experiments. ST463 and ST235 accounted for 9.8% (115/1,168) and 4.5% (53/1,168) of total isolates, respectively, and showed high frequencies of extensively drug-resistant and difficult-to-treat resistant phenotypes. The overall IR-resistant rate in CRPA was 21.0% (245/1,168). However, the IR resistance rate was 81.7% (94/115) in ST463-PA and 52.8% (28/53) in ST235-PA. Of the ST463 isolates, 92.2% (106/115) were Klebsiella pneumoniae carbapenemase-producing P. aeruginosa (KPC-PA), and all 94 IR-resistant ST463-PA produced KPC-2. Compared to IR-susceptible ST463 KPC-2-PA, IR-resistant ST463 KPC-2-PA exhibited significantly higher bla KPC-2 copy numbers and expression levels. In ST463 KPC-2-PA, 16 mg/L relebactam resulted in additional fourfold reductions in imipenem MIC 50/90 values compared to 4 mg/L relebactam. In ST235, 1.9% (1/53) carried bla IMP carbapenemase and 54.7% (29/53) carried bla GES carbapenemase. Other than the IMP producer, all 27 IR-resistant ST235-PA produced GES-5. Cloning experiments revealed that imipenem resistance in bla GES-5 -carrying PAO1 transformants was generally unaffected by relebactam. In conclusion, IR-resistant CRPA isolates in China were mainly distributed in P. aeruginosa high-risk clones ST463 and ST235. The major underlying IR resistance mechanisms were bla KPC-2 overexpression and bla GES-5 carriage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaPseudomonas InfectionsHumansAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsClone CellsImipenemMicrobial Sensitivity TestsAzabicyclo Compounds

Stichwörter der Autor:innen

ST235ST463bla GES-5bla KPC-2carbapenem-resistant Pseudomonas aeruginosahigh-risk cloneimipenem/relebactam

Substanzen

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsImipenemrelebactamAzabicyclo Compoundsbeta-lactamase KPC-2

Autor:innen und Institutionen

  • Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine , Hangzhou, China.
  • Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine , Hangzhou, China.
  • Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province , Hangzhou, China.
  • Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou, China.
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The…

ORCID-Profile: Yue Li, Xiaoting Hua, Yunsong Yu

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • MOST | National Key Research and Development Program of China (NKPs)
  • Merck (Merck & Co.)

Zitieren

APA

Li, Y., Fang, L., Dong, M., Cai, H., Hua, X., Jiang, Y., Yu, Y., & Yang, Q. (2023). bla KPC-2 overexpression and bla GES-5 carriage as major imipenem/relebactam resistance mechanisms in Pseudomonas aeruginosa high-risk clones ST463 and ST235, respectively, in China. Antimicrobial Agents and Chemotherapy, 67(11). https://doi.org/10.1128/aac.00675-23

Vancouver

Li Y, Fang L, Dong M, Cai H, Hua X, Jiang Y, et al. bla KPC-2 overexpression and bla GES-5 carriage as major imipenem/relebactam resistance mechanisms in Pseudomonas aeruginosa high-risk clones ST463 and ST235, respectively, in China. Antimicrobial Agents and Chemotherapy. 2023;67(11). doi:10.1128/aac.00675-23

BibTeX
@article{Li2023,
  author = {Li, Yue and Fang, Li and Dong, Mengqian and Cai, Heng and Hua, Xiaoting and Jiang, Yan and Yu, Yunsong and Yang, Qing},
  title = {bla KPC-2 overexpression and bla GES-5 carriage as major imipenem/relebactam resistance mechanisms in Pseudomonas aeruginosa high-risk clones ST463 and ST235, respectively, in China},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  volume = {67},
  number = {11},
  doi = {10.1128/aac.00675-23}
}
Kostenlos starten →